Macromolecular juggling by ubiquitylation enzymes

BMC Biology

Volumn 11, Issue , 2013, Pages

  Lorenz, Sonja ^a,b   Cantor, Aaron J ^a,b   Rape, Michael ^a,b   Kuriyan, John ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UBIQUITIN PROTEIN LIGASE;

ANIMAL; BIOCATALYSIS; CHEMISTRY; HUMAN; MACROMOLECULE; METABOLISM; PHOSPHORYLATION; PROTEIN TERTIARY STRUCTURE; REVIEW; UBIQUITINATION;

ANIMALS; BIOCATALYSIS; HUMANS; MACROMOLECULAR SUBSTANCES; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; UBIQUITIN-PROTEIN LIGASE COMPLEXES; UBIQUITINATION;

EID: 84879525973     PISSN: None     EISSN: 17417007     Source Type: Journal    
DOI: 10.1186/1741-7007-11-65     Document Type: Review

References (105)

1. Kung Y, Ando N, Doukov TI, Blasiak LC, Bender G, Seravalli J, Ragsdale SW, Drennan CL. Visualizing molecular juggling within a B12-dependent methyltransferase complex. Nature 2012, 484:265-269. 10.1038/nature10916, 3326194, 22419154.
2. Bandarian V, Pattridge KA, Lennon BW, Huddler DP, Matthews RG, Ludwig ML. Domain alternation switches B(12)-dependent methionine synthase to the activation conformation. Nat Struct Biol 2002, 9:53-56. 10.1038/nsb738, 11731805.
3. Bandarian V, Ludwig ML, Matthews RG. Factors modulating conformational equilibria in large modular proteins: a case study with cobalamin-dependent methionine synthase. Proc Natl Acad Sci U S A 2003, 100:8156-8163. 10.1073/pnas.1133218100, 166199, 12832615.
4. Kuriyan J, Krishna TS, Wong L, Guenther B, Pahler A, Williams CH, Model P. Convergent evolution of similar function in two structurally divergent enzymes. Nature 1991, 352:172-174. 10.1038/352172a0, 2067578.
5. Waksman G, Krishna TS, Williams CH, Kuriyan J. Crystal structure of Escherichia coli thioredoxin reductase refined at 2 A resolution. Implications for a large conformational change during catalysis. J Mol Biol 1994, 236:800-816. 10.1006/jmbi.1994.1190, 8114095.
6. Lennon BW, Williams CH, Ludwig ML. Twists in catalysis: alternating conformations of Escherichia coli thioredoxin reductase. Science 2000, 289:1190-1194. 10.1126/science.289.5482.1190, 10947986.
7. Gulick AM. Conformational dynamics in the Acyl-CoA synthetases, adenylation domains of non-ribosomal peptide synthetases, and firefly luciferase. ACS Chem Biol 2009, 4:811-827. 10.1021/cb900156h, 2769252, 19610673.
8. Olsen SK, Capili AD, Lu X, Tan DS, Lima CD. Active site remodelling accompanies thioester bond formation in the SUMO E1. Nature 2010, 463:906-912. 10.1038/nature08765, 2866016, 20164921.
9. Varshavsky A. The Early History of the Ubiquitin Field. Protein Sci 2006, 15:647-654. 10.1110/ps.052012306, 2249785, 16501229.
10. Haglund K, Dikic I. Ubiquitylation and cell signaling. EMBO J 2005, 24:3353-3359. 10.1038/sj.emboj.7600808, 1276169, 16148945.
11. Komander D. The emerging complexity of protein ubiquitination. Biochem Soc Trans 2009, 37:937-953. 10.1042/BST0370937, 19754430.
12. Kulathu Y, Komander D. Atypical ubiquitylation - the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages. Nat Rev Mol Cell Biol 2012, 13:508-523. 10.1038/nrm3394, 22820888.
13. van der Veen AG, Ploegh HL. Ubiquitin-like proteins. Annu Rev Biochem 2012, 81:323-357. 10.1146/annurev-biochem-093010-153308, 22404627.
14. Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998, 67:425-479. 10.1146/annurev.biochem.67.1.425, 9759494.
15. Handley PM, Mueckler M, Siegel NR, Ciechanover A, Schwartz AL. Molecular cloning, sequence, and tissue distribution of the human ubiquitin-activating enzyme E1. Proc Natl Acad Sci U S A 1991, 88:258-262. 10.1073/pnas.88.1.258, 50789, 1986373.
16. Jin J, Li X, Gygi SP, Harper JW. Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging. Nature 2007, 447:1135-1138. 10.1038/nature05902, 17597759.
17. Pelzer C, Kassner I, Matentzoglu K, Singh RK, Wollscheid H-P, Scheffner M, Schmidtke G, Groettrup M. UBE1L2, a novel E1 enzyme specific for ubiquitin. J Biol Chem 2007, 282:23010-23014. 10.1074/jbc.C700111200, 17580310.
18. Chiu Y-H, Sun Q, Chen ZJ. E1-L2 activates both ubiquitin and FAT10. Mol Cell 2007, 27:1014-1023. 10.1016/j.molcel.2007.08.020, 17889673.
19. Michelle C, Vourc'h P, Mignon L, Andres CR. What was the set of ubiquitin and ubiquitin-like conjugating enzymes in the eukaryote common ancestor?. J Mol Evol 2009, 68:616-628. 10.1007/s00239-009-9225-6, 2691932, 19452197.
20. Li W, Bengtson MH, Ulbrich A, Matsuda A, Reddy VA, Orth A, Chanda SK, Batalov S, Joazeiro CAP. Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle's dynamics and signaling. PLoS One 2008, 3:e1487. 10.1371/journal.pone.0001487, 2198940, 18213395.
21. Metzger MB, Hristova VA, Weissman AM. HECT and RING finger families of E3 ubiquitin ligases at a glance. J Cell Sci 2012, 125:531-537. 10.1242/jcs.091777, 3381717, 22389392.
22. Wenzel DMD, Klevit RER. Following Ariadne's thread: a new perspective on RBR ubiquitin ligases. BMC Biol 2012, 10:24-24. 10.1186/1741-7007-10-24, 3305615, 22420831.
23. Wenzel DM, Lissounov A, Brzovic PS, Klevit RE. UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids. Nature 2011, 474:105-108. 10.1038/nature09966, 3444301, 21532592.
24. Eddins MJ, Carlile CM, Gomez KM, Pickart CM, Wolberger C. Mms2-Ubc13 covalently bound to ubiquitin reveals the structural basis of linkage-specific polyubiquitin chain formation. Nat Struct Mol Biol 2006, 13:915-920. 10.1038/nsmb1148, 16980971.
25. Reverter D, Lima CD. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex. Nature 2005, 435:687-692. 10.1038/nature03588, 1416492, 15931224.
26. Yunus AA, Lima CD. Lysine activation and functional analysis of E2-mediated conjugation in the SUMO pathway. Nat Struct Mol Biol 2006, 13:491-499. 10.1038/nsmb1104, 16732283.
27. Zimmerman ES, Schulman BA, Zheng N. Structural assembly of cullin-RING ubiquitin ligase complexes. Curr Opin Struct Biol 2010, 20:714-721. 10.1016/j.sbi.2010.08.010, 3070871, 20880695.
28. Schulman BA. Twists and turns in ubiquitin-like protein conjugation cascades. Protein Sci 2011, 20:1941-1954. 10.1002/pro.750, 3302639, 22012881.
29. Dou H, Buetow L, Hock A, Sibbet GJ, Vousden KH, Huang DT. Structural basis for autoinhibition and phosphorylation-dependent activation of c-Cbl. Nat Struct Mol Biol 2012, 19:184-192. 10.1038/nsmb.2231, 22266821.
30. Kobashigawa Y, Tomitaka A, Kumeta H, Noda NN, Yamaguchi M, Inagaki F. Autoinhibition and phosphorylation-induced activation mechanisms of human cancer and autoimmune disease-related E3 protein Cbl-b. Proc Natl Acad Sci U S A 2011, 108:20579-20584. 10.1073/pnas.1110712108, 3251137, 22158902.
31. Walden H, Podgorski MS, Schulman BA. Insights into the ubiquitin transfer cascade from the structure of the activating enzyme for NEDD8. Nature 2003, 422:330-334. 10.1038/nature01456, 12646924.
32. Walden H, Podgorski MS, Huang DT, Miller DW, Howard RJ, Minor DL, Holton JM, Schulman BA. The structure of the APPBP1-UBA3-NEDD8-ATP complex reveals the basis for selective ubiquitin-like protein activation by an E1. Mol Cell 2003, 12:1427-1437. 10.1016/S1097-2765(03)00452-0, 14690597.
33. Huang DT, Miller DW, Mathew R, Cassell R, Holton JM, Roussel MF, Schulman BA. A unique E1-E2 interaction required for optimal conjugation of the ubiquitin-like protein NEDD8. Nat Struct Mol Biol 2004, 11:927-935. 10.1038/nsmb826, 2862556, 15361859.
34. Huang DT, Paydar A, Zhuang M, Waddell MB, Holton JM, Schulman BA. Structural basis for recruitment of Ubc12 by an E2 binding domain in NEDD8's E1. Mol Cell 2005, 17:341-350. 10.1016/j.molcel.2004.12.020, 15694336.
35. Huang DT, Hunt HW, Zhuang M, Ohi MD, Holton JM, Schulman BA. Basis for a ubiquitin-like protein thioester switch toggling E1-E2 affinity. Nature 2007, 445:394-398. 10.1038/nature05490, 2821831, 17220875.
36. Souphron J, Waddell MB, Paydar A, Tokgöz-Gromley Z, Roussel MF, Schulman BA. Structural dissection of a gating mechanism preventing misactivation of ubiquitin by NEDD8's E1. Biochemistry 2008, 47:8961-8969. 10.1021/bi800604c, 2587436,2587436, 18652489.
37. Lois LM, Lima CD. Structures of the SUMO E1 provide mechanistic insights into SUMO activation and E2 recruitment to E1. EMBO J 2005, 24:439-451. 10.1038/sj.emboj.7600552, 548657, 15660128.
38. Lee I, Schindelin H. Structural insights into E1-catalyzed ubiquitin activation and transfer to conjugating enzymes. Cell 2008, 134:268-278. 10.1016/j.cell.2008.05.046, 18662542.
39. Schulman BA, Harper JW. Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways. Nat Rev Mol Cell Biol 2009, 10:319-331. 10.1038/nrm2673, 2712597, 19352404.
40. Taherbhoy AM, Tait SW, Kaiser SE, Williams AH, Deng A, Nourse A, Hammel M, Kurinov I, Rock CO, Green DR, Schulman BA. Atg8 transfer from Atg7 to Atg3: a distinctive E1-E2 architecture and mechanism in the autophagy pathway. Mol Cell 2011, 44:451-461. 10.1016/j.molcel.2011.08.034, 3277881, 22055190.
41. Hong SB, Kim B-W, Lee K-E, Kim SW, Jeon H, Kim J, Song HK. Insights into noncanonical E1 enzyme activation from the structure of autophagic E1 Atg7 with Atg8. Nat Struct Mol Biol 2011, 18:1323-1330. 10.1038/nsmb.2165, 22056771.
42. Noda NN, Satoo K, Fujioka Y, Kumeta H, Ogura K, Nakatogawa H, Ohsumi Y, Inagaki F. Structural basis of Atg8 activation by a homodimeric E1, Atg7. Mol Cell 2011, 44:462-475. 10.1016/j.molcel.2011.08.035, 22055191.
43. Kaiser SE, Mao K, Taherbhoy AM, Yu S, Olszewski JL, Duda DM, Kurinov I, Deng A, Fenn TD, Klionsky DJ, Schulman BA. Noncanonical E2 recruitment by the autophagy E1 revealed by Atg7-Atg3 and Atg7-Atg10 structures. Nat Struct Mol Biol 2012, 19:1242-1249. 10.1038/nsmb.2415, 3515690, 23142976.
44. Brownell JE, Sintchak MD, Gavin JM, Liao H, Bruzzese FJ, Bump NJ, Soucy TA, Milhollen MA, Yang X, Burkhardt AL, Ma J, Loke H-K, Lingaraj T, Wu D, Hamman KB, Spelman JJ, Cullis CA, Langston SP, Vyskocil S, Sells TB, Mallender WD, Visiers I, Li P, Claiborne CF, Rolfe M, Bolen JB, Dick LR. Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ. Mol Cell 2010, 37:102-111. 10.1016/j.molcel.2009.12.024, 20129059.
45. Taylor SV, Kelleher NL, Kinsland C, Chiu HJ, Costello CA, Backstrom AD, McLafferty FW, Begley TP. Thiamin biosynthesis in Escherichia coli. Identification of ThiS thiocarboxylate as the immediate sulfur donor in the thiazole formation. J Biol Chem 1998, 273:16555-16560. 10.1074/jbc.273.26.16555, 9632726.
46. Appleyard MV, Sloan J, Kana'n GJ, Heck IS, Kinghorn JR, Unkles SE. The Aspergillus nidulans cnxF gene and its involvement in molybdopterin biosynthesis. Molecular characterization and analysis of in vivo generated mutants. J Biol Chem 1998, 273:14869-14876. 10.1074/jbc.273.24.14869, 9614089.
47. Wang C, Xi J, Begley TP, Nicholson LK. Solution structure of ThiS and implications for the evolutionary roots of ubiquitin. Nat Struct Biol 2001, 8:47-51. 10.1038/83041, 11135670.
48. Leimkühler S, Wuebbens MM, Rajagopalan KV. Characterization of Escherichia coli MoeB and its involvement in the activation of molybdopterin synthase for the biosynthesis of the molybdenum cofactor. J Biol Chem 2001, 276:34695-34701. 10.1074/jbc.M102787200, 11463785.
49. Lake MW, Wuebbens MM, Rajagopalan KV, Schindelin H. Mechanism of ubiquitin activation revealed by the structure of a bacterial MoeB-MoaD complex. Nature 2001, 414:325-329. 10.1038/35104586, 11713534.
50. Duda DM, Walden H, Sfondouris J, Schulman BA. Structural analysis of Escherichia coli ThiF. J Mol Biol 2005, 349:774-786. 10.1016/j.jmb.2005.04.011, 15896804.
51. Lehmann C, Begley TP, Ealick SE. Structure of the Escherichia coli ThiS-ThiF complex, a key component of the sulfur transfer system in thiamin biosynthesis. Biochemistry 2006, 45:11-19. 10.1021/bi051502y, 2566941, 16388576.
52. Hochstrasser M. Evolution and function of ubiquitin-like protein-conjugation systems. Nat Cell Biol 2000, 2:E153-E157. 10.1038/35019643, 10934491.
53. Bohnsack RN, Haas AL. Conservation in the mechanism of Nedd8 activation by the human AppBp1-Uba3 heterodimer. J Biol Chem 2003, 278:26823-26830. 10.1074/jbc.M303177200, 12740388.
54. Whitby FG, Xia G, Pickart CM, Hill CP. Crystal structure of the human ubiquitin-like protein NEDD8 and interactions with ubiquitin pathway enzymes. J Biol Chem 1998, 273:34983-34991. 10.1074/jbc.273.52.34983, 9857030.
55. Madden MM, Song W, Martell PG, Ren Y, Feng J, Lin Q. Substrate properties of ubiquitin carboxyl-terminally derived peptide probes for protein ubiquitination. Biochemistry 2008, 47:3636-3644. 10.1021/bi702078m, 18307316.
56. Haas AL, Rose IA. The mechanism of ubiquitin activating enzyme. A kinetic and equilibrium analysis. J Biol Chem 1982, 257:10329-10337.
57. Haas AL, Warms JV, Hershko A, Rose IA. Ubiquitin-activating enzyme. Mechanism and role in protein-ubiquitin conjugation. J Biol Chem 1982, 257:2543-2548.
58. Pickart CM, Kasperek EM, Beal R, Kim A. Substrate properties of site-specific mutant ubiquitin protein (G76A) reveal unexpected mechanistic features of ubiquitin-activating enzyme (E1). J Biol Chem 1994, 269:7115-7123.
59. Durfee LA, Kelley ML, Huibregtse JM. The basis for selective E1-E2 interactions in the ISG15 conjugation system. J Biol Chem 2008, 283:23895-23902. 10.1074/jbc.M804069200, 2527107, 18583345.
60. Wang J, Taherbhoy AM, Hunt HW, Seyedin SN, Miller DW, Miller DJ, Huang DT, Schulman BA. Crystal structure of UBA2(ufd)-Ubc9: insights into E1-E2 interactions in Sumo pathways. PLoS One 2010, 5:e15805. 10.1371/journal.pone.0015805, 3012696, 21209884.
61. Tokgöz Z, Siepmann TJ, Streich F, Kumar B, Klein JM, Haas AL. E1-E2 interactions in ubiquitin and Nedd8 ligation pathways. J Biol Chem 2012, 287:311-321. 10.1074/jbc.M111.294975, 3249083, 22069333.
62. Huang L, Kinnucan E, Wang G, Beaudenon S, Howley PM, Huibregtse JM, Pavletich NP. Structure of an E6AP-UbcH7 complex: insights into ubiquitination by the E2-E3 enzyme cascade. Science 1999, 286:1321-1326. 10.1126/science.286.5443.1321, 10558980.
63. Verdecia MA, Joazeiro CAP, Wells NJ, Ferrer J-L, Bowman ME, Hunter T, Noel JP. Conformational flexibility underlies ubiquitin ligation mediated by the WWP1 HECT domain E3 ligase. Mol Cell 2003, 11:249-259. 10.1016/S1097-2765(02)00774-8, 12535537.
64. Kamadurai HB, Souphron J, Scott DC, Duda DM, Miller DJ, Stringer D, Piper RC, Schulman BA. Insights into ubiquitin transfer cascades from a structure of a UbcH5B approximately ubiquitin-HECT(NEDD4L) complex. Mol Cell 2009, 36:1095-1102. 10.1016/j.molcel.2009.11.010, 2859195, 20064473.
65. Kim HC, Steffen AM, Oldham ML, Chen J, Huibregtse JM. Structure and function of a HECT domain ubiquitin-binding site. EMBO Rep 2011, 12:334-341. 10.1038/embor.2011.23, 3077248, 21399621.
66. Ogunjimi AA, Briant DJ, Pece-Barbara N, Le Roy C, Di Guglielmo GM, Kavsak P, Rasmussen RK, Seet BT, Sicheri F, Wrana JL. Regulation of Smurf2 ubiquitin ligase activity by anchoring the E2 to the HECT domain. Mol Cell 2005, 19:297-308. 10.1016/j.molcel.2005.06.028, 16061177.
67. Pandya RK, Partridge JR, Love KR, Schwartz TU, Ploegh HL. A structural element within the HUWE1 HECT domain modulates self-ubiquitination and substrate ubiquitination activities. J Biol Chem 2010, 285:5664-5673. 10.1074/jbc.M109.051805, 2820794, 20007713.
68. Maspero E, Mari S, Valentini E, Musacchio A, Fish A, Pasqualato S, Polo S. Structure of the HECT:ubiquitin complex and its role in ubiquitin chain elongation. EMBO Rep 2011, 12:342-349. 10.1038/embor.2011.21, 3077247, 21399620.
69. Diao J, Zhang Y, Huibregtse JM, Zhou D, Chen J. Crystal structure of SopA, a Salmonella effector protein mimicking a eukaryotic ubiquitin ligase. Nat Struct Mol Biol 2008, 15:65-70. 10.1038/nsmb1346, 18066077.
70. Lin DY-W, Diao J, Zhou D, Chen J. Biochemical and structural studies of a HECT-like ubiquitin ligase from Escherichia coli O157:H7. J Biol Chem 2011, 286:441-449. 10.1074/jbc.M110.167643, 3013003, 20980253.
71. Lin DY-W, Diao J, Chen J. Crystal structures of two bacterial HECT-like E3 ligases in complex with a human E2 reveal atomic details of pathogen-host interactions. Proc Natl Acad Sci U S A 2012, 109:1925-1930. 10.1073/pnas.1115025109, 3277528, 22308380.
72. Wang M, Pickart CM. Different HECT domain ubiquitin ligases employ distinct mechanisms of polyubiquitin chain synthesis. EMBO J 2005, 24:4324-4333. 10.1038/sj.emboj.7600895, 1356336, 16341092.
73. Kim HC, Huibregtse JM. Polyubiquitination by HECT E3s and the determinants of chain type specificity. Mol Cell Biol 2009, 29:3307-3318. 10.1128/MCB.00240-09, 2698738, 19364824.
74. Gallagher E, Gao M, Liu Y-C, Karin M. Activation of the E3 ubiquitin ligase Itch through a phosphorylation-induced conformational change. Proc Natl Acad Sci U S A 2006, 103:1717-1722. 10.1073/pnas.0510664103, 1413664, 16446428.
75. Wiesner S, Ogunjimi AA, Wang H-R, Rotin D, Sicheri F, Wrana JL, Forman-Kay JD. Autoinhibition of the HECT-type ubiquitin ligase Smurf2 through its C2 domain. Cell 2007, 130:651-662. 10.1016/j.cell.2007.06.050, 17719543.
76. Chaugule VK, Burchell L, Barber KR, Sidhu A, Leslie SJ, Shaw GS, Walden H. Autoregulation of Parkin activity through its ubiquitin-like domain. EMBO J 2011, 30:2853-2867. 10.1038/emboj.2011.204, 3160258, 21694720.
77. Duda DM, Scott DC, Calabrese MF, Zimmerman ES, Zheng N, Schulman BA. Structural regulation of cullin-RING ubiquitin ligase complexes. Curr Opin Struct Biol 2011, 21:257-264. 10.1016/j.sbi.2011.01.003, 3151539, 21288713.
78. Saha A, Deshaies RJ. Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugation. Mol Cell 2008, 32:21-31. 10.1016/j.molcel.2008.08.021, 2644375, 18851830.
79. Yamoah K, Oashi T, Sarikas A, Gazdoiu S, Osman R, Pan Z-Q. Autoinhibitory regulation of SCF-mediated ubiquitination by human cullin 1's C-terminal tail. Proc Natl Acad Sci U S A 2008, 105:12230-12235. 10.1073/pnas.0806155105, 2519045, 18723677.
80. Duda DM, Borg LA, Scott DC, Hunt HW, Hammel M, Schulman BA. Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation. Cell 2008, 134:995-1006. 10.1016/j.cell.2008.07.022, 2628631, 18805092.
81. Feltham R, Bettjeman B, Budhidarmo R, Mace PD, Shirley S, Condon SM, Chunduru SK, McKinlay MA, Vaux DL, Silke J, Day CL. Smac mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerization. J Biol Chem 2011, 286:17015-17028. 10.1074/jbc.M111.222919, 3089546, 21393245.
82. Dueber EC, Schoeffler AJ, Lingel A, Elliott JM, Fedorova AV, Giannetti AM, Zobel K, Maurer B, Varfolomeev E, Wu P, Wallweber HJA, Hymowitz SG, Deshayes K, Vucic D, Fairbrother WJ. Antagonists induce a conformational change in cIAP1 that promotes autoubiquitination. Science 2011, 334:376-380. 10.1126/science.1207862, 22021857.
83. Yin Q, Lin S-C, Lamothe B, Lu M, Lo Y-C, Hura G, Zheng L, Rich RL, Campos AD, Myszka DG, Lenardo MJ, Darnay BG, Wu H. E2 interaction and dimerization in the crystal structure of TRAF6. Nat Struct Mol Biol 2009, 16:658-666. 10.1038/nsmb.1605, 2834951, 19465916.
84. Swaminathan G, Tsygankov AY. The Cbl family proteins: ring leaders in regulation of cell signaling. J Cell Physiol 2006, 209:21-43. 10.1002/jcp.20694, 16741904.
85. Ryan PE, Davies GC, Nau MM, Lipkowitz S. Regulating the regulator: negative regulation of Cbl ubiquitin ligases. Trends Biochem Sci 2006, 31:79-88. 10.1016/j.tibs.2005.12.004, 16406635.
86. Meng W, Sawasdikosol S, Burakoff SJ, Eck MJ. Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase. Nature 1999, 398:84-90. 10.1038/18050, 10078535.
87. Kuriyan J, Darnell JE. An SH2 domain in disguise. Nature 1999, 398:22-3-25.
88. Levkowitz G, Waterman H, Ettenberg SA, Katz M, Tsygankov AY, Alroy I, Lavi S, Iwai K, Reiss Y, Ciechanover A, Lipkowitz S, Yarden Y. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Mol Cell 1999, 4:1029-1040. 10.1016/S1097-2765(00)80231-2, 10635327.
89. Rao N, Lupher ML, Ota S, Reedquist KA, Druker BJ, Band H. The linker phosphorylation site Tyr292 mediates the negative regulatory effect of Cbl on ZAP-70 in T cells. J Immunol 2000, 164:4616-4626.
90. Schmidt MHH, Dikic I. The Cbl interactome and its functions. Nat Rev Mol Cell Biol 2005, 6:907-918. 10.1038/nrm1762, 16227975.
91. Zheng N, Wang P, Jeffrey PD, Pavletich NP. Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases. Cell 2000, 102:533-539. 10.1016/S0092-8674(00)00057-X, 10966114.
92. Umebayashi K, Stenmark H, Yoshimori T. Ubc4/5 and c-Cbl continue to ubiquitinate EGF receptor after internalization to facilitate polyubiquitination and degradation. Mol Biol Cell 2008, 19:3454-3462. 10.1091/mbc.E07-10-0988, 2488299, 18508924.
93. Huang A, de Jong RN, Wienk H, Winkler GS, Timmers HTM, Boelens R. E2-c-Cbl recognition is necessary but not sufficient for ubiquitination activity. J Mol Biol 2009, 385:507-519. 10.1016/j.jmb.2008.10.044, 18996392.
94. Yokouchi M, Kondo T, Sanjay A, Houghton A, Yoshimura A, Komiya S, Zhang H, Baron R. Src-catalyzed phosphorylation of c-Cbl leads to the interdependent ubiquitination of both proteins. J Biol Chem 2001, 276:35185-35193. 10.1074/jbc.M102219200, 11448952.
95. Liu J, Kimura A, Baumann CA, Saltiel AR. APS facilitates c-Cbl tyrosine phosphorylation and GLUT4 translocation in response to insulin in 3T3-L1 adipocytes. Mol Cell Biol 2002, 22:3599-3609. 10.1128/MCB.22.11.3599-3609.2002, 133825, 11997497.
96. Kassenbrock CK, Anderson SM. Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations. J Biol Chem 2004, 279:28017-28027. 10.1074/jbc.M404114200, 15117950.
97. Bartkiewicz M, Houghton A, Baron R. Leucine zipper-mediated homodimerization of the adaptor protein c-Cbl. A role in c-Cbl's tyrosine phosphorylation and its association with epidermal growth factor receptor. J Biol Chem 1999, 274:30887-30895. 10.1074/jbc.274.43.30887, 10521482.
98. Peschard P, Kozlov G, Lin T, Mirza IA, Berghuis AM, Lipkowitz S, Park M, Gehring K. Structural basis for ubiquitin-mediated dimerization and activation of the ubiquitin protein ligase Cbl-b. Mol Cell 2007, 27:474-485. 10.1016/j.molcel.2007.06.023, 17679095.
99. Kozlov G, Peschard P, Zimmerman B, Lin T, Moldoveanu T, Mansur-Azzam N, Gehring K, Park M. Structural basis for UBA-mediated dimerization of c-Cbl ubiquitin ligase. J Biol Chem 2007, 282:27547-27555. 10.1074/jbc.M703333200, 17635922.
100. Fischer ES, Scrima A, Böhm K, Matsumoto S, Lingaraju GM, Faty M, Yasuda T, Cavadini S, Wakasugi M, Hanaoka F, Iwai S, Gut H, Sugasawa K, Thomä NH. The molecular basis of CRL4DDB2/CSA ubiquitin ligase architecture, targeting, and activation. Cell 2011, 147:1024-1039. 10.1016/j.cell.2011.10.035, 22118460.
101. Calabrese MF, Scott DC, Duda DM, Grace CRR, Kurinov I, Kriwacki RW, Schulman BA. A RING E3-substrate complex poised for ubiquitin-like protein transfer: structural insights into cullin-RING ligases. Nat Struct Mol Biol 2011, 18:947-949. 10.1038/nsmb.2086, 3245743, 21765416.
102. Liu J, Nussinov R. Flexible cullins in cullin-RING E3 ligases allosterically regulate ubiquitination. J Biol Chem 2011, 286:40934-40942. 10.1074/jbc.M111.277236, 3220518, 21937436.
103. Chao WCH, Kulkarni K, Zhang Z, Kong EH, Barford D. Structure of the mitotic checkpoint complex. Nature 2012, 484:208-213. 10.1038/nature10896, 22437499.
104. Herzog F, Primorac I, Dube P, Lenart P, Sander B, Mechtler K, Stark H, Peters J-M. Structure of the anaphase-promoting complex/cyclosome interacting with a mitotic checkpoint complex. Science 2009, 323:1477-1481. 10.1126/science.1163300, 2989460, 19286556.
105. Olsen SK, Lima CD. Structure of a ubiquitin E1-E2 complex: insights to E1-E2 thioester transfer. Mol Cell 2013, 49:884-896. 10.1016/j.molcel.2013.01.013, 23416107.